Eli Lilly and Company (BVMF:LILY34)
177.99
+4.08 (2.35%)
Last updated: Nov 12, 2025, 3:26 PM GMT-3
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of 4.83 trillion as of November 13, 2025. Its market cap has increased by 4.80% in one year.
Market Cap
4.83T
Enterprise Value
5.00T
Revenue
316.67B
Ranking
n/a
PE Ratio
49.18
Stock Price
177.99
Market Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 4.83T, an increase of 156,052.46%. That is a compound annual growth rate of 14.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 4.83T | 12.25% |
| Dec 31, 2024 | 4.30T | 69.02% |
| Dec 29, 2023 | 2.54T | 38.42% |
| Dec 30, 2022 | 1.84T | 31.71% |
| Dec 31, 2021 | 1.40T | 75.52% |
| Dec 31, 2020 | 794.91B | 56.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 2.94B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |